Opportunity remains despite regulatory and access obstacles.
Karina Ikeda
Advertisement
Karina Ikeda is a senior consultant within the life sciences practice at Guidehouse
Articles by Karina Ikeda
Advertisement
Latest Updated Articles
The JAKs Journey Offers Valuable Lessons for InnovatorsPublished: February 17th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
5
